Immunogenic composition and uses thereof
US9889195B2 · kind B2 · utility
3Cited by
2References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 22, 2015 |
| Grant date | Feb 13, 2018 |
| Priority date | — |
| Expiry date | Jan 22, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/6018
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an immunogenic composition comprising an antigen and a dendritic cell targeting component. A charged group is covalently attached to a dendritic cell ligand and is electrostatically associated with the dendritic cell targeting component.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.